Related Experiment Video
Updated: Jun 24, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Nonfasting hyperlipidemia and cardiovascular disease
B G Nordestgaard1, A Langsted, J J Freiberg
1Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Denmark. brno@heh.regionh.dk
Nonfasting lipid profiles, including triglycerides, are clinically relevant for predicting cardiovascular disease risk. Measuring lipids in a nonfasting state simplifies blood tests and can improve patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Clinical Chemistry
- Lipid Metabolism
Background:
- Lipid profiles are typically measured in a fasting state, despite most individuals being nonfasting.
- Recent evidence suggests minimal clinical impact of normal food intake on key lipid values.
Purpose of the Study:
- To evaluate the clinical significance of nonfasting lipid levels for cardiovascular disease risk prediction.
- To explore the potential of nonfasting lipid profiles for simplifying patient blood sampling.
Main Methods:
- Analysis of nonfasting levels of various lipids, lipoproteins, and apolipoproteins.
- Correlation of nonfasting lipid markers with cardiovascular disease risk factors like myocardial infarction and stroke.
Main Results:
- Elevated nonfasting triglycerides, as a marker for remnant lipoprotein cholesterol, strongly associate with increased risk of myocardial infarction, ischemic stroke, and mortality.
- Nonfasting levels of total cholesterol, non-HDL cholesterol, LDL cholesterol, apolipoprotein B, triglycerides, HDL cholesterol, apolipoprotein A1, and their ratios all correlate with cardiovascular disease risk.
Conclusions:
- Nonfasting lipid profiles are as effective as fasting profiles for cardiovascular risk prediction.
- Shifting to nonfasting lipid measurements could simplify clinical practice and improve patient management.
- Further research, including randomized trials, is needed to assess therapeutic interventions targeting nonfasting lipids.
Related Concept Videos
Lipids: Dietary Sources and Requirements
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...
